{"id":"W2061337936","doi":"10.1200/jco.2013.54.2456","title":"Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30<sup>+</sup> Peripheral T-Cell Lymphomas: Results of a Phase I Study","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"ca_institutions":"Seagen (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Takeda Oncology","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Neutropenia; Vincristine; CHOP; Anaplastic large-cell lymphoma; Febrile neutropenia; Adverse effect; Gastroenterology; Phases of clinical research; Oncology; Surgery; Cyclophosphamide; Lymphoma; Chemotherapy; CD30","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001986474,0.0002247235,0.002051708,0.0001257471,0.00002729979,0.000005683609,0.0001918491,0.0001753654,0.00004722996],"category_scores_gemma":[0.0008500417,0.0001062657,0.0004332376,0.0001382,0.0001869626,0.0000609139,0.00002679417,0.000195407,0.00000393683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003425888,"about_ca_system_score_gemma":0.0008326747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000206623,"about_ca_topic_score_gemma":0.0001336435,"domain_scores_codex":[0.9949279,0.000991939,0.003003105,0.0002470678,0.0005937149,0.0002362949],"domain_scores_gemma":[0.9944369,0.002354587,0.002192017,0.0003974044,0.0004206352,0.0001985058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0353211,0.1891557,0.6463308,0.00002099296,0.0005607218,0.0003062407,0.002687222,0.0001272237,0.000005263117,0.000006719026,0.0003775522,0.1251004],"study_design_scores_gemma":[0.23515,0.2304839,0.5256593,0.0000865894,0.0009015069,0.00002787244,0.001013417,0.0003823645,0.00008326435,0.00001564101,0.006122345,0.0000738329],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964136,0.0002364648,0.00001234111,0.001216452,0.0001750409,0.0007673593,0.0000279979,0.000003280885,0.001147484],"genre_scores_gemma":[0.9982808,0.0001789147,0.000798608,0.0003113551,0.0003116853,0.00001967235,0.00001614547,0.00001532741,0.00006754078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1998289,"threshold_uncertainty_score":0.433339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0600788206171172,"score_gpt":0.4065655712450807,"score_spread":0.3464867506279635,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}